News
Italian Biotech company Kedrion Biopharma plans plasma-based treatment launch for COVID-19 by late summer of 2020
Kedrion plans to use plasma from about 100 patients who have recovered from COVID-19 in order to develop a dosage that can be injected intravenous or intramuscularly.
